XML 25 R5.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income $ 4,640,000,000 $ 5,088,000,000
Less: Net income attributable to the noncontrolling interest 59,000,000 44,000,000
Net income attributable to Honeywell 4,581,000,000 5,044,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:    
Depreciation 500,000,000 558,000,000
Amortization 319,000,000 304,000,000
Repositioning and other charges 306,000,000 756,000,000
Net payments for repositioning and other charges (157,000,000) (519,000,000)
Pension and other postretirement income (484,000,000) (769,000,000)
Pension and other postretirement benefit payments (50,000,000) (67,000,000)
Stock compensation expense 112,000,000 131,000,000
Deferred income taxes (298,000,000) (482,000,000)
Other 98,000,000 (163,000,000)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:    
Accounts receivable (78,000,000) 131,000,000
Inventories (276,000,000) (459,000,000)
Other current assets (68,000,000) 356,000,000
Accounts payable (89,000,000) 466,000,000
Accrued liabilities (133,000,000) (412,000,000)
Net cash provided by (used for) operating activities 4,283,000,000 4,875,000,000
Cash flows from investing activities:    
Expenditures for property, plant and equipment (504,000,000) (522,000,000)
Proceeds from disposals of property, plant and equipment 41,000,000 4,000,000
Increase in investments (3,218,000,000) (2,882,000,000)
Decrease in investments 3,318,000,000 4,634,000,000
Cash paid for acquisitions, net of cash acquired (4,000,000) (51,000,000)
Other 245,000,000 250,000,000
Net cash provided by (used for) investing activities (122,000,000) 1,433,000,000
Cash flows from financing activities:    
Proceeds from issuance of commercial paper and other short-term borrowings 10,292,000,000 19,300,000,000
Payments of commercial paper and other short-term borrowings (10,293,000,000) (19,153,000,000)
Proceeds from issuance of common stock 425,000,000 242,000,000
Proceeds from issuance of long-term debt 2,725,000,000 26,000,000
Payments of long-term debt (120,000,000) (1,303,000,000)
Repurchases of common stock (3,650,000,000) (2,308,000,000)
Cash dividends paid (1,798,000,000) (1,669,000,000)
Preseparation Funding 0 1,604,000,000
Other (72,000,000) (141,000,000)
Net cash provided by (used for) financing activities (2,491,000,000) (3,402,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents (49,000,000) (162,000,000)
Net increase (decrease) in cash and cash equivalents 1,621,000,000 2,744,000,000
Cash and cash equivalents at beginning of period 9,287,000,000 7,059,000,000
Cash and cash equivalents at end of period $ 10,908,000,000 $ 9,803,000,000